Weakness and wasting in the critically ill patient

Current Anaesthesia and Critical Care

Volumn 7, Issue 2, 1996, Pages 81-86

  O'Leary, M J ^a   Coakley, J H ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE;

CRITICAL ILLNESS; HUMAN; MALNUTRITION; METABOLISM; MUSCLE ATROPHY; NITROGEN BALANCE; NUTRITIONAL SUPPORT; PHYSIOTHERAPY; PRIORITY JOURNAL; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029929143     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-7112(96)80062-7     Document Type: Article

References (19)

1. Elia M. Changing concepts of nutrient requirements in disease: Implications for artificial nutritional support. Lancet 1995; 345: 1279-1289.
2. Arnold J, Campbell I T, Samuels T A, et al. Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. Clin Sci 1993; 84: 655-661.
3. Souba W. Cytokine control of nutrition and metabolism in critical illness. Curr Probl Surg 1994; 31(7): 577-643.
4. Ross R, Miell J, Freeman E, et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1. Clin Endocrinol 1991; 35: 47-54.
5. Douglass J, Tuxen D, Home M, Sheinkestel C. Myopathy in severe asthma. Am Rev Respir Dis 1992; 146: 517-519.
6. Barrett S, Mourain S, Villareal C, Gonzales J, Zimmerman J. Rhabdomyolysis associated with status asthmaticus. Crit Care Med 1993; 21: 151-153.
7. O'Leary M, Honavar M, Coakley J. Acute necrotizing myopathy and acute renal failure in association with acute severe asthma. Anaesth Intensive Care 1994; 22: 729-732.
8. Helliwell T, Coakley J, Wagenmakers A, et al. Necrotizing myopathy in critically ill patients. J Pathol 1991; 164: 307-314.
9. Coakley J H, Nagendran K, Honavar M, Hinds C J. Preliminary observations on the neurorauscular abnormalities in critically ill patients. Int Care Med 1993; 19(6): 323-328.
10. Witt N, Zochodne D, Bolton C, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99(1): 176-184.
11. Gorson K, Ropper A. Acute respiratory failure neuropathy: A variant of critical illness polyneuropathy. Crit Care Med 1993; 21(2): 267-271.
12. Souba W W, Austgen T R. Interorgan glutamine flow following surgery and infection. JPEN 1990; 14(suppl 4): 90S-93S.
13. Parry-Billings M, Baigrie R J, Lamont P M, Morris P J, Newsholme E A. Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg 1992; 127: 1237-1240.
14. Elia M. Glutamine in parenteral nutrition. Int J Food Sci Nutr 1992; 43: 47-49.
15. Daly M, Liekerman M, Foldfine J, et al. Enteral nutrition with supplemental arginine, RNA and omega-3 fatty acids in patients after operation: Immunologic, metabolic and clinical outcomes. Surgery 1992; 112: 56-57.
16. Coakley J, Yarwood G, Ross R. The pathophysiology of neuromuscular weakness: Potential of treatment with growth factors. In: Vincent J-L, (ed) Intensive Care and Emergency Medicine Update 1993. Springer Verlag, 1993: 178-184.
17. Hammarqvist F, Strömberg C, von der Decken A, Vinnars E, Wernerman J. Biosynthetic human growth hormone preserves both muscle protein synthesis and the decrease in muscle-free glutamine, and improves whole body nitrogen economy after operation. Ann Surg 1992; 16(2): 184-191.
18. Manson J M, Smith R J, Wilmore D W. Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Ann Surg 1988; 208: 136-142.
19. Ross R, Yarwood G, Coakley J. Prospective therapeutic use of growth hormone and IGF-1 in ICU patients. In: Intensive Care Britain 1993. London: Greycote Publishing, 1993: 45-48.